Market Capitalization

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

Photo editor Fotor unveils its AI Vibe Marketing Platform, leveraging deep AI research to help small businesses create high-performance visuals instantly.

The acquisition creates a $7.6B regional powerhouse, sparking questions about the future of community banking for customers, employees, and competitors.

As landmark U.S. crypto regulation nears and institutional interest shifts, a new AI tool from AIX Alpha aims to help traders navigate XRP's volatility.

Riverside ditches its .fm roots for a .com domain, cementing its evolution from a niche podcast tool to an AI-powered, all-in-one content creation studio.

Celebrating a half-century of progress, Liberty Hill Foundation's anniversary gala was an urgent plea to fund the fight for Los Angeles's future.

CFO Martin Fischer's reappointment secures leadership continuity, reinforcing Fresenius Medical Care's focus on financial discipline and long-term growth.

Two iconic American brands partner to reclaim the spritz, blending Michigan cider and California bubbly for a new patriotic cocktail celebrating 250 years.

The U.S. Army's $49M NCODE pilot offers a lifeline to contractors, validating secure enclave solutions like Beryllium's Cuick Trac for CMMC compliance.

A massive $910M deal with Ares Real Estate cements Scion's market dominance, signaling a new gold rush for institutional investors in student housing.

Expedia Group's reported $350M deal for CarTrawler signals a major push to dominate the B2B travel market, integrating cars, transport, and insurance.

A new partnership enables compliant crypto-to-fiat funding for gaming, blending digital asset liquidity with robust responsible betting frameworks.

With a new $75M, Boston Metal scales its MOE tech to produce clean, critical metals from waste, aiming to secure supply chains and decarbonize industry.

Fintech lender Octane expands its partnership with investment giant Nuveen, bolstering its funding to meet soaring demand in powersports and RV financing.

With the hire of Brandi Healey, Hawkeye Partners signals a strategic shift to build an in-house powerhouse in the booming senior housing market.

Led by OrbiMed, the financing will propel Accro's promising oral RIPK2 inhibitor for Ulcerative Colitis into a pivotal Phase IIb clinical trial.

A new high-yield product is luring Australia's $1.06T SMSF sector. But is the promise of high returns from private credit worth the risk?

The digital bank is rolling out a suite of new investment funds, including a multi-asset portfolio and a physical gold fund, for retail investors.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

As graphene leader NanoXplore appoints CEO Rocco Marinaccio to its board, the move signals a push for faster growth but raises timeless governance questions.